1LB 5-year overall survival update from the X-ACT trial of capecitabine vs. 5-FU/LV as adjuvant treatment for stage-III colon cancer

✍ Scribed by C. Twelves; W. Scheithauer; J. McKendrick; M. Nowacki; J. Seitz; G. Van Hazel; A. Wong; E. Diaz-Rubio; J. Cassidy

• Book ID: 118624937
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 38 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70094-0